Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01957085 · ClinicalTrials.gov registry record
Undiagnosed Hepatitis C Infection in an Urban Hospital
A clinical trial, sponsored by Temple University.
- Completed
- Registry status
- 366
- Enrollment target
NCT01957085: Completed study, sponsored by Temple University.
NCT01957085 is a clinical trial that has completed, run by Temple University. The registered enrollment target is 366 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01957085 has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- 366 participants
- Enrollment target
Study Summary
The Centers for Disease Control and Prevention estimates that there are approximately 3.2 million people in the United States infected with hepatitis C and a significant percentage of these patients are unaware of their diagnosis. This study will attempt to determine the point prevalence of undiagnosed hepatitis C infection in an urban hospital population. All patients admitted to the hospital on two separate days will have hepatitis C testing done on leftover serum and plasma that was collected as part of routine inpatient lab work. Our primary goal is to determine the number of undiagnosed hepatitis C infected patients in our hospitalized population. We will also compare these rates to specific demographic characteristics, such as age, race, gender, zip code and type of insurance to see if any associations exist between these demographics and undiagnosed hepatitis C infection.
Primary Outcome
The point prevalence of hepatitis C infection in our hospitalized patients will be measured on a single day. All leftover plasma/serum samples will be de-identified and tested for hepatitis C antibody and if antibody positive will be tested for hepatitis C polymerase chain reaction. Results reported as percentage of subjects who are viremic.
Interventions
- OTHER observation only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 366 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-01 |
What the finished NCT01957085 record still lists
NCT01957085 is an observational study that tracks outcomes without assigning an intervention. The registered 366 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which observation only is the first listed.
NCT01957085 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01957085 about?
NCT01957085 is a clinical study titled "Undiagnosed Hepatitis C Infection in an Urban Hospital". The Centers for Disease Control and Prevention estimates that there are approximately 3.2 million people in the United States infected with hepatitis C and a significant percentage of these patients are unaware of their diagnosis. This study will attempt to determine the point prevalence of undiagno...
What is the current status of trial NCT01957085?
This trial is currently completed. The enrollment target is 366 participants. The study started on 2014-06. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01957085?
The interventions under investigation include: observation only (OTHER).
Who is sponsoring clinical trial NCT01957085?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05083481 · 366 participants · Phase 1
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors
- NCT05429632 · 366 participants · Phase 3
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
- NCT06979453 · 366 participants · Phase 3
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- NCT04049604 · 365 participants · NA
IDENTIFY Study: Natural History of Maternal Neoplasia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia